RSPH Fees and Costs — Invesco S&P 500 Equal Weight Health Care ETF
Data updated: 2026-09-28
The net expense ratio is 0.40%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $29K in broker commissions, 0.0040% of average net assets, and portfolio turnover was 24%.
RSPH Fees and Expenses
Annual operating expenses and sales charges of RSPH. Prospectus, as of August 27, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.40% |
| 12b-1 fee | — |
| Other expenses | 0.00% |
| Gross expense ratio | 0.40% |
| Fee waiver | — |
| Net expense ratio | 0.40% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
RSPH Costs Over Time
On $10,000 invested in RSPH, assuming 5% a year before costs, total costs come to $256 over 5 years, cutting the return by 0.42% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.40%) | $42 | $132 | $230 |
| Trading costs (broker commissions) | $0 | $1 | $2 |
| Lost growth on money paid in costs | $0 | $7 | $23 |
| Total costs | $42 | $140 | $256 |
| Value after costs | $10,458 | $11,437 | $12,507 |
| Impact on return, per year | 0.42% | 0.42% | 0.42% |
RSPH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending April 30, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0040%
- Total broker commissions: $29K
- Bought from dealers (principal trades, not a cost): $221.0M
- Portfolio turnover (prospectus): 24%
- Securities on loan, average value: $23.9M
- Net income from securities lending: $37K (0.005% of average net assets)
RSPH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| CITIGROUP GLOBAL MARKETS INC. | $15K | 53.20% |
| INVESCO CAPITAL MARKETS, INC. | $5K | 16.83% |
| WELLS FARGO SECURITIES, LLC | $4K | 12.82% |
| UBS SECURITIES LLC | $2K | 6.69% |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $909 | 3.18% |
| MORGAN STANLEY & CO. LLC | $760 | 2.66% |
| VIRTU AMERICAS LLC | $382 | 1.33% |
| ACADEMY SECURITIES, INC. | $338 | 1.18% |
| JEFFERIES LLC | $316 | 1.11% |
| BTIG, LLC | $288 | 1.01% |
RSPH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| CITADEL SECURITIES LLC | $47.6M | 21.58% |
| RBC CAPITAL MARKETS, LLC | $42.3M | 19.17% |
| BNY MELLON CAPITAL MARKETS, LLC | $41.8M | 18.95% |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INC. | $38.5M | 17.46% |
| JANE STREET CAPITAL, LLC | $18.5M | 8.37% |
| VIRTU AMERICAS LLC | $12.7M | 5.76% |
| MORGAN STANLEY & CO. LLC | $8.7M | 3.96% |
| HRT Financial LP | $5.5M | 2.49% |
| GOLDMAN, SACHS & CO. | $2.8M | 1.26% |
| BNP PARIBAS SECURITIES CORP. | $2.2M | 1.01% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.